Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Trauma Sessions: 2017 AANS Annual Scientific Meeting

    Includes Credits

    Earn up to 5.5 trauma CME credits and receive access to the recorded trauma-related sessions from the 2017 AANS Annual Scientific Meeting, including named lectures, abstract presentations and discussions. AANS Member: $179 | Non-member: $239

    Earn up to 5.5 trauma CME credits and receive access to the recorded trauma-related sessions from the 2017 AANS Annual Scientific Meeting, including named lectures, abstract presentations and discussions.

    PRICING

    AANS Member: $179 | Non-member: $239

    LEARNING OBJECTIVES

    Upon completion of this CME activity, participants should be able to:

    • Discuss research updates in trauma neurosurgery
    • Apply updates in trauma neurosurgery to practice

     FACULTY INFORMATION

    Fernando Alonso, MD

    William J. Ares, MD

    Anthony O Asemota, MD, MPH

    Amrit Chiluwal, MD

    Andrew Benjamin Cutler, MD

    Christopher Paul Deibert, MD

    Marcus Gates, MD

    Joanna Elizabeth Gernsback, MD

    John Peter Gruen, MD

    Jian Guan, MD

    Ryan S. Hirschi

    Seth A. Hoffer, MD

    Peter John Hutchinson, MD

    Jennifer Jennings, MD

    Panagiotis Kerezoudis, MD

    Churl-Su Kwon

    Nikita Lakomkin

    Wei-Lun Lo, MD

    Asim Mahmood, MD

    Peter T McCunniff

    Joshua Eric Medow, MD, MS*

    Daniel Bernard Michael, MD, PhD

    Ali Kemal Ozturk, MD

    Marios C. Papadopoulos, MD

    Dmitriy Petrov, MD

    Craig H. Rabb, MD

    Patricia B. Raksin, MD

    Franco Servadei, MD

    Diem Kieu Thi Tran, MD

    Eve C. Tsai, MD, PhD

    Aditya Vedantam, MD

    John K. Yue

    Joseph Christopher Zacko, MD*

     

    *Indicates a planner of this activity

     

    DISCLOSURE INFORMATION

    The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

     

    The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

     

    It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

     

    All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

     

    Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may have a relevance to their presentation are listed below.

    Name

    Company Name

    Relationship

    Peter John Hutchinson, MD

    Codman

    Speaker’s Bureau

    Joshua Eric Medow, MD, MS

    The Hartwell Foundation, The Batterman Foundation, iVMD

    Abbott Labs

    Grants/Research Support

     

    Stock Shareholder (Purchased Direct i.e. not through Mutual Fund, retirement package, etc.)

    Eve C. Tsai, MD, PhD

    Vertex, Rick Hansen Foundation

    Grants/Research Support

     

     

    Those who have reported they do not have any relationships with commercial interests:

    Fernando Alonso, MD

    William J. Ares, MD

    Anthony O Asemota, MD, MPH

    Amrit Chiluwal, MD

    Andrew Benjamin Cutler, MD

    Christopher Paul Deibert, MD

    Marcus Gates, MD

    Joanna Elizabeth Gernsback, MD

    John Peter Gruen, MD

    Jian Guan, MD

    Ryan S. Hirschi

    Seth A. Hoffer, MD

    Jennifer Jennings, MD

    Panagiotis Kerezoudis, MD

    Churl-Su Kwon

    Nikita Lakomkin

    Wei-Lun Lo, MD

    Asim Mahmood, MD

    Peter T McCunniff

    Daniel Bernard Michael, MD, PhD

    Ali Kemal Ozturk, MD

    Marios C. Papadopoulos, MD

    Dmitriy Petrov, MD

    Craig H. Rabb, MD

    Patricia B. Raksin, MD

    Franco Servadei, MD

    Diem Kieu Thi Tran, MD

    Aditya Vedantam, MD

    John K. Yue

    Joseph Christopher Zacko, MD

     

     

     

    DISCLAIMER

    The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

     

    Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve

     

    ACCREDITATION/DESIGNATION

    The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

     

    The AANS designates this enduring material for a maximum of 5.5 AMA PRA Category 1 Credit TM.

    Physicians should claim only credit commensurate with the extent of their participation in the activity.

     

    Term of approval is for three years, beginning from 6/30/2017 until 6/30/2020.

     

    Upon successful completion of the CME quiz, AANS Members will see their CME will automatically reflected in their record.  Nonmembers may can print a certificate for their records.

     

    Time to complete this activity varies by learner. For this activity you may earn up to 5.5 AMA PRA Category 1 Credit™.

     

    Copyright © 2017 American Association of Neurological Surgeons 

  • APP Plenary Session: 2017 AANS Annual Scientific Meeting

    Includes Credits

    Video recordings from the 2017 AANS Annual Scientific Meeting Advanced Practice Provider (APP) Plenary Session include presentations on spine, pain, coding and traumatic brain injury – all geared specifically for the neurosurgical nurse practitioner (NP) and physicians assistiant (PA). 7.0 CME credits available. AANS Member $199 | Non-member $249

    Video recordings from the 2017 AANS Annual Scientific Meeting Advanced Practice Provider (APP) Plenary Session include presentations on spine, pain, coding and traumatic brain injury – all geared specifically for the neurosurgical nurse practitioner (NP) and physicians assistiant (PA). 7.0 CME credits available

    AANS Member $199 | Non-member $249

    LEARNING OBJECTIVES

    Upon completion of this CME activity, participants should be able to:

    • Discuss research updates in neurosurgery
    • Apply updates in neurosurgery to clinical practice

     

    FACULTY INFORMATION

    Nitin Agarwal, MD*

    Arun Paul Amar, MD

    Frederick A. Boop, MD

    Marcus Gates, MD

    Ebonye Green, APRN

    Hector E. James, MD

    Steven N. Kalkanis, MD

    Kent Kilbourn, PA-C

    Denise Lally-Goss, ANP

    Marianne E. Langlois, MS, PA-C*

    Cristina Matthews, MSN, FNP-BC*

    Steven G. Ojemann, MD

    Rabia Qaiser, MD

    Robert W.J. Ryan, MD

    Nikhil Sharma

    Kristina Shultz, NP-C

    Izabela Tarasiewicz, MD

    Darren Wong, MD

     

    *Indicates a planner of this activity

     

    DISCLOSURE INFORMATION

    The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

     

    The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

     

    It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

     

    All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

     

    Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may have a relevance to their presentation are listed below.

    Name

    Company Name

    Relationship

    Arun Paul Amar, MD

    Medtronic Neurovascular

    Other Financial Support

    Frederick A. Boop, MD

    American Board of Pediatric Neurosurgery

     

     

     

     

    Medtronic

    Semmes-Murphey Clinc

    Board/Trustee/Officer/Leadership position specifically with a neurosurgical or medical-related associated non-profit or similar entity, Employee (any industry)

    Consultant Fees

    Employee (any industry)

    Marianne E. Langlois, MS, PA-C

    Codman Neuroscience

    Consultant Fees

    Steven G. Ojemann, MD

    Medtronic

    Alpha Omega Engineering

    Consultant Fees

    Speaker’s Bureau

    Robert W.J. Ryan, MD

    Penumbra, Inc.

    Consultant Fees, Speaker’s Bureau

     

     

    Those who have reported they do not have any relationships with commercial interests:

    Nitin Agarwal, MD

    Marcus Gates, MD

    Ebonye Green, APRN

    Hector E. James, MD

    Steven N. Kalkanis, MD

    Kent Kilbourn, PA-C

    Denise Lally-Goss, ANP

    Cristina Matthews, MSN, FNP-BC

    Rabia Qaiser, MD

    Nikhil Sharma

    Kristina Shultz, NP-C

    Izabela Tarasiewicz, MD

    Darren Wong, MD

     

     

     

    DISCLAIMER

    The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

     

    Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve

     

    ACCREDITATION/DESIGNATION

    The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

     

    The AANS designates this enduring material for a maximum of 7.0 AMA PRA Category 1 Credit TM.

    Physicians should claim only credit commensurate with the extent of their participation in the activity.

     

    Term of approval is for three years, beginning from 6/30/2017 until 6/30/2020.

     

    Upon successful completion of the CME quiz, AANS Members will see their CME will automatically reflected in their record.  Nonmembers may can print a certificate for their records.

     

    Time to complete this activity varies by learner. For this activity you may earn up to 7.0 AMA PRA Category 1 Credit™.

     

    Copyright © 2017 American Association of Neurological Surgeons 

  • Introduction To Neuroimaging: Spine

    Includes Credits

    This webinar will provide an introduction to spine imaging for the advanced practice provider. The goal of this session will be to review radiography, computed tomography (CT) and magnetic resonance imaging (MRI) of the spine, discuss the strengths and differences of each modality for common pathologies, review indications and appropriateness criteria for imaging and how to choose the ideal study for common clinical scenarios, and review imaging features of commonly encountered spinal pathologies.

    This webinar will provide an introduction to spine imaging for the advanced practice provider. The goal of this session will be to review radiography, computed tomography (CT) and magnetic resonance imaging (MRI) of the spine, discuss the strengths and differences of each modality for common pathologies, review indications and appropriateness criteria for imaging and how to choose the ideal study for common clinical scenarios, and review imaging features of commonly encountered spinal pathologies. 

    Member: $69 Non-Member: $119

    Learning Objectives

    1. Review the normal radiologic anatomy of the spine on radiograph, CT, and MRI

    2.  Discuss the strengths and differences of each modality for common pathologies

    3. Describe indications and appropriateness criteria for imaging and how to choose the ideal study for common clinical scenarios

    4. Review imaging features of commonly encountered spinal pathologies

    Margaret Chapman, MD

    Dr. Margaret Chapman is an Assistant Professor of Radiology and Program Director of the Radiology Residency at Boston University School of Medicine. She completed her MD at Tufts University School of Medicine, Diagnostic Radiology residency at Boston University Medical Center, and Neuroradiology fellowship at the University of Washington Medical Center in Seattle, Washington. She is a board certified radiologist with an additional Certificate of Additional Qualification in Neuroradiology

    Prior to medical school, Dr. Chapman earned her AB in Biology from Cornell University in Ithaca, NY, graduating with distinction and honors. She was then employed at Roche Pharmaceuticals in Palo Alto, California, in the department of Inflammatory and Viral Diseases Unit, where her responsibilities included utilizing the sub-genomic Hepatitis C Virus (HCV) replicon as a model for interrogating small molecule antiviral efficacy, several of which were enrolled in clinical trials.

    Dr. Chapman’s interests include head and neck imaging and imaging of brain tumors. 

    DISCLOSURE INFORMATION The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information. In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

    The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

    It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities. Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

    All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

    Those who have reported they do not have any relationships with commercial interests: Margaret Chapman, MD; Katy Meyer

    DISCLAIMER The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products. 

    Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve

    ACCREDITATION/DESIGNATION The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

    The AANS designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

    Term of approval is for three years, beginning from 06/14/2017 until 06/14/2020. 

    After completing the activity and successful completion of the test, AANS members will be able to see the CME automatically reflected in your record and you can print a certificate. Non-Members must print a CME certificate and retain it for your records.

    Time to complete this activity varies by learner. For this activity you may earn up to 1.0 AMA PRA Category 1 Credit™.

    Copyright© 2017American Association of Neurological Surgeons. All rights reserved.

  • 2017 AANS Annual Scientific Meeting

    View recorded sessions from the AANS Annual Scientific Meeting, including the Opening Ceremonies, Plenary Sessions, Section Sessions, International Symposium and more. More than 80 hours of recorded content. $799 Member | $999 Non-member | Free to Attendees

    View the full recorded sessions from the 2017 AANS Annual Scientific Meeting, with more than 80 hours of presentations. Refer back to these sessions in any order, at any time you like from your smartphone, tablet or personal computer.

    Recorded sessions include:

    • Opening Ceremonies
    • Plenary Sessions
    • AANS/CNS Section Sessions
    • Subspecialty-focused Sessions
    • Young Neurosurgeons Research Forum
    • Advanced Practice Provider Plenary Session
    • International Symposium

    Pricing
    Free to Attendees | $799 Member | $999 Non-member

  • Best of 2017 AANS Annual Scientific Meeting

    Includes Credits

    Selected highlights from the 2017 AANS Annual Scientific Meeting, including 30 of the highest-rated abstracts, the Opening Ceremonies roundtable discussion and more. 2.75 CME credits available. $149 Member | $199 Non-member

    AANS 2017 Best Of

    The 2017 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Los Angeles had its share of highlights. For those who couldn’t attend, this collection of recordings provides online access to:

    • 30 of the Highest-graded Oral Abstracts Presented
    • Opening Ceremonies’ Roundtable Discussion on Global Neurosurgery
    • Three Historical Films on Neurosurgeons in Hollywood
    • The President’s Address, Cushing Oration and Rhoton Family Lecture
    • 2.75 AMA PRA Category 1 Credit(s)™ 

    REGISTRATION

    $149 AANS Member | $199 Non-member

    LEARNING OBJECTIVES

    Upon completion of this CME activity, participants should be able to:

    • Discuss research updates in neurosurgery
    • Apply recent clinical research to practice

     FACULTY INFORMATION

    Owoicho Adogwa, MD

    Fawaz Al-Mufti, MD

    William J. Ares, MD

    Sarah Kathleen Bourne Bick, MD

    Robert Francis Dallapiazza, MD

    Samer K. Elbabaa, MD

    Richard G. Fessler, MD, PhD

    Zhongzheng Fu

    Ryan S. Hirschi

    Arman Jahangiri

    Holger Joswig, MD

    Thomas J. Leipzig, MD, FAANS*

    Andre Guelman Machado, MD, PhD

    Neil R. Malhotra, MD

    Tanya Minasian, DO

    Mick J. Perez-Cruet, MD

    Jarod Roland, MD

    Juan Santiago Uribe, MD

    Doris Du Wang, MD, PhD

    Mark William Youngblood

     

    *Indicates a planner of this activity

     

    DISCLOSURE INFORMATION

    The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

     

    The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

     

    It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

     

    All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

    Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may have a relevance to their presentation are listed below.

    Name

    Company Name

    Relationship

    Richard G. Fessler, MD, PhD

    DePuy Synthes

    Benvenue

    Stryker

    In Queue Innovations

    Consultant

    Consultant/Speaker’s Bureau

    Other Financial Support

    Board/Trustee/Officer/Leadership position that could affect an entities' finances

    Holger Joswig, MD

    Fujirebio Europe N.V. (Ghent, Belgium)

    Grants/Research Support

    Andre Guelman Machado, MD, PhD

    Enspire

     

    ATI, Cardionomics, Medtronic

    NIH

    Functional Neuromodulation

    Consultant Fees, Grants/Research Support, Other Financial Support

    Other Financial Support

    Grants/Research Support

    Consultant Fees

    Neil R. Malhotra, MD

    Johnson and Johnson

    Consultant Fees

    Mick J. Perez-Cruet, MD

    MI4Spine, Thompson MIS

    Stock Shareholder (purchased direct i.e. not through Mutual Fund, retirement package, etc.)

    Jarod Roland, MD

    Intellectual Ventures, Monteris Medical, Acera Medical, Pear Therapeutics, General Sensing

     

    General Sensing, Neurolutions, Osteovantage, Face to Face Biometrics, Pear Therapeutics

    Consultant Fees

     

     

     

    Stock Shareholder (purchased direct i.e. not through Mutual Fund, retirement package, etc.)

    Juan Santiago Uribe, MD

    Nuvasive

    Consultant Fees, Stock Shareholder (purchased direct i.e. not through Mutual Fund, retirement package, etc.)

     

     

    Those who have reported they do not have any relationships with commercial interests:

    Owoicho Adogwa, MD

    Fawaz Al-Mufti, MD

    William J. Ares, MD

    Sarah Kathleen Bourne Bick, MD

    Robert Francis Dallapiazza, MD

    Samer K. Elbabaa, MD

    Zhongzheng Fu

    Ryan S. Hirschi

    Arman Jahangiri

    Tanya Minasian, DO

    Doris Du Wang, MD, PhD

    Mark William Youngblood

     

     

    DISCLAIMER

    The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

     

    Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve

     

    ACCREDITATION/DESIGNATION

    The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

     

    The AANS designates this educational activity for a maximum of 2.75 AMA PRA Category 1 Credit TM.

    Physicians should claim only credit commensurate with the extent of their participation in the activity.

     

    Term of approval is for three years, beginning from 6/30/2017 until 6/30/2020.

     

    Upon successful completion of the CME quiz, AANS Members will see their CME will automatically reflected in their record.  Nonmembers may can print a certificate for their records.

     

    Time to complete this activity varies by learner. For this activity you may earn up to 2.75 AMA PRA Category 1 Credit™.

    Copyright © 2017 American Association of Neurological Surgeons


  • The Spetzler Symposium

    More than 75 faculty present on neurosurgical themes most closely linked to the career of Robert F. Spetzler, MD, FAANS, including craniovertebral junction, skull base, complex/deep brain tumors and cerebrovascular surgery. $299 Member | $399 Non-member | Free to Attendees

    Spetzler SymposiumHundreds attended this two-day symposium, April 20-21, 2017, celebrating the career and accomplishments of Robert F. Spetzler, MD, FAANS.

    For those unable to attend, the symposium is now accessible as an online course. 

    Description
    More than 75 national and international neurosurgical masters and leaders in the field present, and more than 17 hours of presentations were recorded covering the topics most indelibly linked to Dr. Spetzler’s career: 

    • Craniovertebral junction
    • Skull base
    • Complex/deep brain tumors
    • Cerebrovascular surgery

    Pricing
    $299 Member | $399 Non-member | Free to Attendees

    Learning Objectives
    At the end of this educational event, participants will be able to:

    • Identify different pathologies at the craniovertebral junction.
    • Choose the appropriate surgical approach for specific lesions of the craniovertebral junction.
    • Differentiate various skull base lesions and understand the benefits and limitations of most available skull base approaches (open versus endoscopic).
    • Apply the different open and endovascular methods to the treatment of intracranial aneurysms and vascular malformations.
    • Familiarize themselves with the advanced techniques of brain mapping and surgical removal of gliomas.
  • What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid (5-ALA) for Fluorescence-Guided Surgery of Brain Tumors?

    The Neurosurgery Research & Education Foundation (NREF) with support from Leica Microsystems presents this free webinar, led by Costas G. Hadjipanayis, MD, PhD, FAANS.

    Faculty:
     
    Costas G. Hadjipanayis, MD, PhD, FAANS

    Professor and Chair
    Dept. of Neurosurgery, Mount Sinai Beth Israel

    Director, Neurosurgical Oncology
    Mount Sinai Health System
    Icahn School of Medicine at Mount Sinai

    Director, Brain Tumor Nanotechnology Laboratory
    Tisch Cancer Institute
     

    Course Description:
     
    This webinar will examine the surgical benefit of using 5-ALA for fluorescence-guided surgery (FGS) of brain tumors. The participants will be introduced to the concept of FGS and understand how 5-ALA can help neurosurgeons identify in real-time tumor tissue for resection purposes. As part of this webinar, 5-ALA in different tumor types will be discussed mainly focusing on malignant gliomas. The safety aspects of 5-ALA administration will be discussed in addition to the current state of regulatory approval for use in the United States.


    Learning Objectives:
     
    Upon completion of this activity, participants should be able to:
     
    -Identify 5-ALA and its intracellular fluorescent metabolite, protoporphyrin IX in brain tumors.

    -Discuss the technical aspects of 5-ALA fluorescence-guided surgery including the use of 5-ALA FGS for real-time intraoperative guidance, tumor margin visualization, and reported extents of resection.

    -Review patient safety and the current state of regulatory approval of 5-ALA.

    -Recognize the surgical benefits of 5-ALA for fluorescence-guided surgery.
     
     
    ***This webinar does not provide CME credit.
     

    Costas G. Hadjipanayis

    MD, PhD, FAANS

    Professor and Chair
    Dept. of Neurosurgery, Mount Sinai Beth Israel


    Director, Neurosurgical Oncology
    Mount Sinai Health System
    Icahn School of Medicine at Mount Sinai


    Director, Brain Tumor Nanotechnology Laboratory
    Tisch Cancer Institute

    How did you hear about this Webinar?


    Please login to access this poll.
  • Cerebral Metastatic Disease

    This presentation provides information on the epidemiology, pathogenesis, and management options for patients with brain metastases. Free to Members and NonMembers

    LEARNING OBJECTIVES
    Upon completion of this activity, participants should be able to:
    Identify factors that impact survival in patients with metastatic brain tumors.
    Recognize the role of radiotherapy in patients with metastatic brain tumors.
    Describe the role of surgery in patients with metastatic brain tumors.
    Define the growing role of radiosurgery in patients with metastatic brain tumors.

    FACULTY INFORMATION

    Jonas Sheehan, MD, FAANS
    Penn State Hershey Medical Center
    Hershey, Pennsylvania

    DISCLAIMER
    The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products. 

    Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve

    Copyright© 2012 American Association of Neurological Surgeons. All rights reserved.

  • Current Applications and Advances in Fluorescence Guided Surgery

    The Neurosurgery Research & Education Foundation (NREF) with support from Leica Microsystems presents this free webinar entitled, “Current Applications and Advances in Fluorescence-guided Surgery,” led by Costas G. Hadjipanayis, MD, PhD, FAANS. Free for Members and NonMembers.

    Faculty:
     
    Costas G. Hadjipanayis, MD, PhD, FAANS

    Professor and Chair
    Dept. of Neurosurgery
    Mount Sinai Beth Israel

    Director of Neurosurgical Oncology
    Mount Sinai Health System

    Director, Mount Sinai Brain Tumor Nanotechnology Laboratory
    Tisch Cancer Institute at Mount Sinai
    Icahn School of Medicine at Mount Sinai


    Course Description:
     
    Participants will be receive an overview on the concept of fluorescence-guided surgery (FGS) for the resection of brain and spinal cord tumors. Neurosurgeons will understand the current technologies available for FGS and the different tumor types that can undergo FGS. Safety, diagnostic accuracy, and Level 1 evidence in support of FGS will also be discussed.


    Learning Objectives:
     
    Upon completion of this activity, participants should be able to:
     
    ~ Define the use of FGS for brain tumors with 5-aminolevulinic acid (5-ALA) and fluorescein
    ~ Identify different brain and spinal cord tumor types that are amenable to FGS 
    ~ Distinguish the technical aspects of FGS, including the use of FGS for real-time intraoperative guidance, tumor margin visualization, and reported extents of tumor resection.
    ~ Explain patient safety with FGS
    ~ Demonstrate the difference between current and future FGS microscope technology; and
    ~ Summarize the current US regulatory state for FGS.
     
    ***This webinar does not provide CME credit.
     

    Costas G. Hadjipanayis

    MD, PhD, FAANS

    Professor and Chair
    Dept. of Neurosurgery, Mount Sinai Beth Israel


    Director, Neurosurgical Oncology
    Mount Sinai Health System
    Icahn School of Medicine at Mount Sinai


    Director, Brain Tumor Nanotechnology Laboratory
    Tisch Cancer Institute

  • Coagulopathy Reversal Approaches & DVT Protocols for Trauma Patients

    An online course that will address anticoagulation approaches and recent updates to DVT prevention guidelines. Faculty will discuss coagulopathy reversal cases and a pharmacologic prophylaxis quality improvement initiative.

    LEARNING OBJECTIVES
    Upon completion of this CME activity, participants should be able to: 
    1. Apply the coagulation cascade to fix coagulopathies
    2. Describe guidelines for the prevention of thrombosis in craniotomy and spine surgery patients
    3. Review a pharmacologic prophylaxis quality improvement initiative

    FACULTY INFORMATION
    Joshua Medow, MD, MS, FAANS
    University of Wisconsin Hospital and Clinics
    Madison, WI

    Christopher Zacko, MD
    Penn State University
    Hershey, PA

    DISCLAIMER
    The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

    Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve

    Copyright © 2013 American Association of Neurological Surgeons